St James's Place PLC
F:1IV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
St James's Place PLC
F:1IV
|
UK |
|
T
|
T Rowe Price Group Inc
XMUN:TR1
|
US |
|
Ameren Corp
NYSE:AEE
|
US |
|
ELQ SA
F:7DP
|
PL |
|
Arovella Therapeutics Ltd
F:E4NA
|
AU |
|
Medexus Pharmaceuticals Inc
F:P731
|
CA |
|
E
|
Eurofins Scientific SE
XMUN:ESF0
|
LU |
|
N
|
Nissin Foods Holdings Co Ltd
XMUN:NF2
|
JP |
|
N
|
New Hope Corporation Ltd
F:OD8
|
AU |
Wall St Price Targets
1IV Price Targets Summary
St James's Place PLC
According to Wall Street analysts, the average 1-year price target for 1IV is 22.25 EUR with a low forecast of 17.42 EUR and a high forecast of 28.56 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1IV's stock price target?
Price Target
22.25
EUR
According to Wall Street analysts, the average 1-year price target for 1IV is 22.25 EUR with a low forecast of 17.42 EUR and a high forecast of 28.56 EUR.
What is the Revenue forecast for St James's Place PLC?
Projected CAGR
-46%
The compound annual growth rate for Revenue over the next 5 years is -46%.
What is the Net Income forecast for St James's Place PLC?
Projected CAGR
14%
Over the last 14 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 6 years is 14%.
